AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75F40122C00137AMERICANS FOR INDIAN OPPORTUNITY, INC.
Overview
Award facts
- Net obligations
- $855.58K
- $855,584of $855.58K potential value
- Outlays (paid to date)
- $855.58K
- $855.58K paid of $855.58K obligated$855,584
- Period of performance
- Sep 27, 2022 to Sep 27, 2024
- Ended
- Modifications
- 1
- Latest action Oct 3, 2023
- Contract type
- Definitive contract
- PIID 75F40122C00137
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
BAA -SSBSWP 194/OC-2022-111835 - STIMULATE INNOVATION IN CLINICAL EVALUATION AND PERSONALIZED MEDICINE TO IMPROVE OUTCOMES IN DIVERSE POPULATIONS.
Dates and value
- Award date
- Signed on Sep 27, 2022
- Potential end of performance
- Sep 26, 2024
- Current value
- $855,584Base and exercised options
- Potential value (if all options are exercised)
- $855,584
Obligations by fiscal year of action
- FY2022: $855,584
Total across 1 fiscal year: $855,584
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 3, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationALBUQUERQUE, NM
UEIQAXBZZYHL291
CAGE code9CZS4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyAMERICANS FOR INDIAN OPPORTUNITY, INC.
Business types and certifications
Minority-ownedNonprofit organizationTax-exempt corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Coronavirus emergency funding supplementalProgram activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Silver Spring, Montgomery County, Maryland 20993-0001
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Basic researchBR
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 165
Solicitation and notices
- Solicitation ID
- FDA BAA-22-00123
- Solicitation date
- Nov 10, 2021
- Notices
- Solicitation posted Jan 20, 2022
- Solicitation posted Jan 7, 2022
- Solicitation posted Jan 7, 2022
- Solicitation posted Nov 10, 2021
- Solicitation posted Nov 10, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 27, 2022Base obligation at award: $855,584
- Latest action
- Oct 3, 2023 — Other administrative actionModification P00001; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $855,584
- COVID-19 supplemental outlays
- $855,584